Wegovy injection offers a powerful approach to weight management. This FDA-approved, once-weekly semaglutide (2.4 mg/0.75 mL) GLP-1 medication helps reduce hunger, enhance fullness, and promote fat loss. It also supports healthy insulin levels and balances blood sugar. Administered as a simple subcutaneous injection, it contributes to significant weight reduction, with an average loss of 15% of body weight over 12 months.
